Benzinga's M&A Chatter for Tuesday September 17, 2013

The following are the M&A deals, rumors and chatter circulating on Wall Street for Tuesday September 17, 2013: Report Clovis Oncology Considering Sale The Rumor:
Shares of Clovis Oncology CLVS rocketed higher Tuesday on a report from Bloomberg that the company is considering a possible sale. A spokesperson for Clovis Oncology told Benzinga the company was not the source of the Bloomberg report and declined further comment. On June 3, shares surged over $86.00 as the company reported positive results from phase I/II study of CO-1686 treatment for small cell lung cancer. Clovis Oncology closed well off the highs Tuesday at $72.44, a gain of more than 7%. Rockwood to Sell Titanium Dioxide Pigments Business, Other Non-Strategic Businesses to Huntsman for $1.325B The Deal:
Rockwood Holdings ROC announced Tuesday that it has agred to sell its Titanium Dioxide Pigments and four other non-strategic businesses to Huntsman Corporation HUN for an enterprise value of $1.325 billion, including the assumption of $225 million in pension obligations The deal is expected to close during H1 2014. Rockwood Holdings closed at $67.21 Tuesday, a gain of almost 1%, while Huntsman closed at $19.50, a gain of almost 2%. Hearing Renewed Takeover Chatter in Whiting Petroleum The Rumor:
Shares of Whiting Petroleum WLL rose in early trading Tuesday on renewed takeover chatter. Spain's Repsol REPYY is the rumored bidder at a reported $75 per share. Statoil STO has been mentioned most often as a possible buyer. A spokesperson for Whiting declined comment on the rumor. A Repsol spokesperson was not available for comment. Whiting Petroleum closed at $54.78 Tuesday, a gain of 3.71%.